What's New

Last Posted: May 30, 2019

• Assessment of tumor mutation burden calculation from gene panel sequencing data.
  Xu Zhenwu et al. OncoTargets and therapy 2019 123401-3409
• Pathologist-level classification of histopathological melanoma images with deep neural networks.
  Hekler Achim et al. European journal of cancer (Oxford, England : 1990) 2019 May 11579-83
• The Impact of Genetic Counseling Educational Tools on Patients' Knowledge of Molecular Testing Terminology.
  McDaniels Brianna A et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2019 May
• Precision Medical Approaches to the Diagnoses and Management of Brain Metastases.
  Chukwueke Ugonma N et al. Current treatment options in oncology 2019 May 20(6) 49
• Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.
  Haslam Alyson, et al. JAMA network open 2019 5 0. (5) e192535
• Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task.
  Brinker Titus J, et al. European journal of cancer (Oxford, England : 1990) 2019 4 0. 47-54
• Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
  Leof Emma R et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Apr
• Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result.
  Zhu Xuan et al. Public health genomics 2019 Apr 21(3-4) 154-163
• Analysis of the CDKN2A gene in FAMMM Syndrome families reveals early age of onset for additional syndromic cancers.
  Middlebrooks Candace D et al. Cancer research 2019 Apr
• Epigenetic Classifiers for Precision Diagnosis of Brain Tumors.
  Orozco Javier Ij et al. Epigenetics insights 2019 122516865719840284
• Machine Learning in Medicine.
  Rajkomar Alvin et al. The New England journal of medicine 2019 Apr 380(14) 1347-1358
• Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial.
  Janda Monika et al. Dermatology (Basel, Switzerland) 2019 235(1) 11-18
• Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
  Smit Amelia K et al. European journal of human genetics : EJHG 2018 26(8) 1094-1100
• Assessing long-term survival benefits of immune checkpoint inhibitors using the net survival benefit.
  Péron Julien et al. Journal of the National Cancer Institute 2019 Mar
• Implementing TMB measurement in clinical practice: considerations on assay requirements.
  Büttner Reinhard et al. ESMO open 2019 4(1) e000442